The durability of the pulmonary autograft after Ross procedure in patients with rheumatic aortic valve disease

Background The pulmonary autograft is the ideal aortic valve substitute in young patients with aortic valve disease. Performing Ross procedure in patients with rheumatic heart disease is controversial as the autograft might be susceptible to recurrent rheumatic activity and early autograft dysfuncti...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed Magdi Youssef, Waheed Etman, Akram Refaat Allam, Ahmed Mahgoub, Karimeldeen Hafez, Ahmed Afifi
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Alexandria Journal of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/20905068.2024.2414366
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849228963803561984
author Ahmed Magdi Youssef
Waheed Etman
Akram Refaat Allam
Ahmed Mahgoub
Karimeldeen Hafez
Ahmed Afifi
author_facet Ahmed Magdi Youssef
Waheed Etman
Akram Refaat Allam
Ahmed Mahgoub
Karimeldeen Hafez
Ahmed Afifi
author_sort Ahmed Magdi Youssef
collection DOAJ
description Background The pulmonary autograft is the ideal aortic valve substitute in young patients with aortic valve disease. Performing Ross procedure in patients with rheumatic heart disease is controversial as the autograft might be susceptible to recurrent rheumatic activity and early autograft dysfunction. The aim of the study is to evaluate the durability of the pulmonary autograft in series of patients with rheumatic aortic valve disease. This is a retrospective study enrolling patients who were admitted for Ross procedure and had a preoperative diagnosis of rheumatic heart disease from October 2009 to July 2021. Preoperative, intraoperative and postoperative data were collected from hospital records. Follow-up transthoracic echocardiogram was used to assess the autograft function, and Kaplan–Meier Curve was plotted to evaluate freedom from autograft dysfunction.Results The study included 28 patients who had Ross procedure with root replacement technique. The primary valve derangement is aortic regurgitation, and concomitant mitral disease requiring surgery was found in 32% of the patients. No operative mortality was recorded, and only one patient had late death throughout the follow-up period. Follow-up was complete in 75% of the cohort and the median follow-up was 4.75 years (range from 2 to 11.9 years). Freedom from any autograft dysfunction was 94.7% at 10 years. None of the patients required reintervention for the pulmonary autograft. Three patients had a total of 4 reinterventions; 2 for the homograft and 2 for the mitral valve.Conclusions Ross procedure remains a good option for replacing the aortic valve in young patients with rheumatic heart disease in the light of the good durability of the pulmonary autograft and the superior survival. Although longer follow-up duration and bigger sample size is needed to draw more significant results, the excellent initial outcomes guided by experienced hands should promote the use of Ross procedure in such cohort of patients.
format Article
id doaj-art-cc1aa7f5d0724dc8b9eb5a6579985029
institution Kabale University
issn 2090-5068
2090-5076
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Alexandria Journal of Medicine
spelling doaj-art-cc1aa7f5d0724dc8b9eb5a65799850292025-08-22T11:30:31ZengTaylor & Francis GroupAlexandria Journal of Medicine2090-50682090-50762025-12-016111510.1080/20905068.2024.2414366The durability of the pulmonary autograft after Ross procedure in patients with rheumatic aortic valve diseaseAhmed Magdi Youssef0Waheed Etman1Akram Refaat Allam2Ahmed Mahgoub3Karimeldeen Hafez4Ahmed Afifi5Department of Cardiothoracic Surgery, Faculty of Medicine, Alexandria University, Alexandria, EgyptDepartment of Cardiothoracic Surgery, Faculty of Medicine, Alexandria University, Alexandria, EgyptDepartment of Cardiothoracic Surgery, Faculty of Medicine, Alexandria University, Alexandria, EgyptDepartment of Cardiac Surgery, Magdi Yacoub Foundation Aswan Heart Centre, EgyptDepartment of Cardiology, Magdi Yacoub Foundation Aswan Heart Centre, EgyptDepartment of Cardiac Surgery, Magdi Yacoub Foundation Aswan Heart Centre, EgyptBackground The pulmonary autograft is the ideal aortic valve substitute in young patients with aortic valve disease. Performing Ross procedure in patients with rheumatic heart disease is controversial as the autograft might be susceptible to recurrent rheumatic activity and early autograft dysfunction. The aim of the study is to evaluate the durability of the pulmonary autograft in series of patients with rheumatic aortic valve disease. This is a retrospective study enrolling patients who were admitted for Ross procedure and had a preoperative diagnosis of rheumatic heart disease from October 2009 to July 2021. Preoperative, intraoperative and postoperative data were collected from hospital records. Follow-up transthoracic echocardiogram was used to assess the autograft function, and Kaplan–Meier Curve was plotted to evaluate freedom from autograft dysfunction.Results The study included 28 patients who had Ross procedure with root replacement technique. The primary valve derangement is aortic regurgitation, and concomitant mitral disease requiring surgery was found in 32% of the patients. No operative mortality was recorded, and only one patient had late death throughout the follow-up period. Follow-up was complete in 75% of the cohort and the median follow-up was 4.75 years (range from 2 to 11.9 years). Freedom from any autograft dysfunction was 94.7% at 10 years. None of the patients required reintervention for the pulmonary autograft. Three patients had a total of 4 reinterventions; 2 for the homograft and 2 for the mitral valve.Conclusions Ross procedure remains a good option for replacing the aortic valve in young patients with rheumatic heart disease in the light of the good durability of the pulmonary autograft and the superior survival. Although longer follow-up duration and bigger sample size is needed to draw more significant results, the excellent initial outcomes guided by experienced hands should promote the use of Ross procedure in such cohort of patients.https://www.tandfonline.com/doi/10.1080/20905068.2024.2414366Ross Procedurerheumatic heart diseasepulmonary autograftpulmonary homograftreinterventions
spellingShingle Ahmed Magdi Youssef
Waheed Etman
Akram Refaat Allam
Ahmed Mahgoub
Karimeldeen Hafez
Ahmed Afifi
The durability of the pulmonary autograft after Ross procedure in patients with rheumatic aortic valve disease
Alexandria Journal of Medicine
Ross Procedure
rheumatic heart disease
pulmonary autograft
pulmonary homograft
reinterventions
title The durability of the pulmonary autograft after Ross procedure in patients with rheumatic aortic valve disease
title_full The durability of the pulmonary autograft after Ross procedure in patients with rheumatic aortic valve disease
title_fullStr The durability of the pulmonary autograft after Ross procedure in patients with rheumatic aortic valve disease
title_full_unstemmed The durability of the pulmonary autograft after Ross procedure in patients with rheumatic aortic valve disease
title_short The durability of the pulmonary autograft after Ross procedure in patients with rheumatic aortic valve disease
title_sort durability of the pulmonary autograft after ross procedure in patients with rheumatic aortic valve disease
topic Ross Procedure
rheumatic heart disease
pulmonary autograft
pulmonary homograft
reinterventions
url https://www.tandfonline.com/doi/10.1080/20905068.2024.2414366
work_keys_str_mv AT ahmedmagdiyoussef thedurabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT waheedetman thedurabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT akramrefaatallam thedurabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT ahmedmahgoub thedurabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT karimeldeenhafez thedurabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT ahmedafifi thedurabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT ahmedmagdiyoussef durabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT waheedetman durabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT akramrefaatallam durabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT ahmedmahgoub durabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT karimeldeenhafez durabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease
AT ahmedafifi durabilityofthepulmonaryautograftafterrossprocedureinpatientswithrheumaticaorticvalvedisease